COVID-19 CD40 Pan CoV

N/A

Report date: 2025/01/26 17:21:16

Base Information

Drug NameCOVID-19 CD40 Pan CoV
Drug Alias NameCD40-targeted prophylactic vaccine (LinKinVax/GTP Bioways)COVID-19 ANTI-CD40 CoV2
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 modulators
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLinKinVax
China Registration ClassN/A

Develop Information

Active CompaniesGTP Bioways SASLinKinVax
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A